Circulating levels of gastrointestinal hormones in prediabetes reversing to normoglycemia or progressing to diabetes in a year-A cross-sectional and prospective analysis.
Incretins
Proglucagon-Derived Peptides
Type 2 Diabetes Mellitus
Journal
Diabetes research and clinical practice
ISSN: 1872-8227
Titre abrégé: Diabetes Res Clin Pract
Pays: Ireland
ID NLM: 8508335
Informations de publication
Date de publication:
May 2023
May 2023
Historique:
received:
26
01
2023
revised:
01
03
2023
accepted:
16
03
2023
medline:
16
5
2023
pubmed:
21
3
2023
entrez:
20
3
2023
Statut:
ppublish
Résumé
We aimed to compare the concentrations of GLP-1, glucagon and GIP (established regulators of glucose homeostasis) and glicentin (emerging new metabolic marker)during an OGTT in patients with normal glucose tolerance (NGT), prediabetes and diabetes at onset, and one-year before, when all had prediabetes. GLP-1, glucagon, GIP and glicentin concentrations were measured and compared with markers of body composition, insulin sensitivity and β-cell function at a 5-timepoint OGTT in 125 subjects (30 diabetes, 65 prediabetes, 30 NGT) and in 106 of them one-year before, when all had prediabetes. At baseline, when all subjects were in prediabetic state, hormonal levels did not differ between groups. One year later, patients progressing to diabetes had lower postprandial increases of glicentin and GLP-1, lower postprandial decrease of glucagon, and higher levels of fasting GIP compared to patients regressing to NGT. Changes in glicentin and GLP-1 AUC within this year correlated negatively with changes in Glucose AUC of OGTT and with changes in markers of beta cell function. Incretins, glucagon and glicentin profiles in prediabetic state cannot predict future glycemic traits, but prediabetes progressing to diabetes is accompanied by deterioration of postprandial increases of GLP-1 and glicentin.
Identifiants
pubmed: 36940795
pii: S0168-8227(23)00396-0
doi: 10.1016/j.diabres.2023.110636
pii:
doi:
Substances chimiques
Gastrointestinal Hormones
0
Glucagon
9007-92-5
Insulin
0
Glicentin
71567-77-6
Blood Glucose
0
Glucagon-Like Peptide 1
89750-14-1
Gastric Inhibitory Polypeptide
59392-49-3
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
110636Informations de copyright
Copyright © 2023 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The current study was funded by transCampus Dresden- King’s College London Science to Business Initiative funded from Deutsche Foschungsgemeinschaft (DFG) [C6] and by BundesministeriumfürBildung und Foschung (BMBF) – DeutschesZentrumfürDiabetesforschung (DZD e.V.). C.H. was funded by a fellowship from Deutsche Diabetes Gesellschaft (DDG).